Various genes such as vascular endothelial cadherin (VE-cadherin) and erythropoietin-producing hepatocellular receptor A2 (EphA2), and signaling pathways including the phosphoinositide 3-kinase/AKT pathway participate in VM formation by aggressive tumor cells [9,11]. This evidence concerns the gene EPHA2 and neoplasm.